US EditionWest to Participate in Upcoming Investor Conferences
- West Pharmaceutical Services, Inc., headquartered in Exton, Pennsylvania, announced on May 7, 2025, it will present at two upcoming investor conferences.
- The company made the announcement to inform investors of its scheduled presentations at the BofA Securities Healthcare Conference on May 14 and William Blair Growth Stock Conference on June 5, 2025.
- West is a global company with a workforce of more than 10,000 employees operating out of 50 locations, including 25 manufacturing plants, producing upwards of 41 billion components annually and achieving net sales of $2.89 billion in fiscal year 2024.
- West will present at the BofA conference on May 14, 2025, at 2:20 PM PT and at the William Blair conference on June 5, 2025, at 10:40 AM CT, with live webcasts available on its website www.westpharma.com.
- These presentations could enhance West’s visibility among investors, supporting ongoing engagement as a global leader traded on the NYSE under ticker WST and included in the S&P 500 index.
35 Articles
35 Articles
The Berkshire Eagle
West to Participate in Upcoming Investor Conferences
EXTON, Pa., May 7, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the BofA Securities Annual Healthcare Conference on Wednesday, May 14,…
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. (WST) - West Pharmaceutical Servs (NYSE:WST)
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of all persons or entities who purchased or otherwise acquired West Pharmaceutical Services, Inc. ("West Pharmaceutical" or the "Company") (NYSE:WST) securities between February 16, 2023 and February 12, 2025, both dates inclusiv…
Shareholder Alert: Robbins LLP Informs Investors of the West Pharmaceutical Services, Inc. Class Action Lawsuit
SAN DIEGO, May 7, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16,…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
